Picture of Scancell Holdings logo

SCLP Scancell Holdings Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Annual cashflow statement for Scancell Holdings, fiscal year end - April 30th, GBP millions except per share, conversion factor applied.

2019
April 30th
2020
April 30th
2021
April 30th
2022
April 30th
2023
April 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-6.71-6.77-16.8-3.77-14.3
Depreciation
Non-Cash Items-0.269-0.0218.3-8.843.11
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.0711.970.4491.682.15
Change in Accounts Receivable
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-7.03-4.77-7.8-10.2-8.14
Capital Expenditures-0.003-0.027-0.744-1.27-0.203
Purchase of Fixed Assets
Other Investing Cash Flow Items0.0150.0140.0030.0040.284
Other Investing Cash Flow
Cash from Investing Activities0.012-0.013-0.741-1.260.081
Financing Cash Flow Items-0.083-0.05-1.41-0.537-0.537
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.283.846.1-0.928-0.746
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-5.74-0.98537.5-12.4-8.8